Abstract
© 2009 The Authors. doi: 10.2340/00015555-0651 Journal Compilation © 2009 Acta Dermato-Venereologica. ISSN 0001-5555 Sir, Hepatorenal syndrome (HRS) is defined as a functional renal failure complicating end-stage cirrhosis. Its prognosis is very poor, liver transplantation being the only definitive treatment. During recent years, vasoactive agents such as terlipressin have been used as a bridge to transplantation (1–6). Terlipressin is currently licensed for the management of acute variceal bleeding (3, 6), but its effects on survival outcomes in HRS are still undefined (4). Only case reports and small series are available, but the results are promising and suggest terlipressin as an efficacious and safe choice (1, 2, 4).
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
